Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT05751824
Starting soon Not applicable

Evaluating the Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients

NCT05751824 · tracked via the Priya Life Science China tracker
Sponsor
Renmin Hospital of Wuhan University
Phase
Not applicable
Started
2023-02-26
Last updated
2023-03-09

Condition(s) studied

Artificial IntelligenceSurveillance

Investigational drug(s) / intervention(s)

AI based automatic surveillance (AS) system (ENDOANGEL-AS)Manually remind the patients to review.

AI based automatic surveillance (AS) system (ENDOANGEL-AS): An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times.

Manually remind the patients to review.: Medical staff remind patients to review by telephone.

Study summary

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of colorectal postpolypectomy patients. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups were compared.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male or female aged 18 years or older who undergo colonoscopy. Exclusion Criteria: * 1)No pathological result. * 2\) No or invalid contact information. * 3\) The surveillance interval cannot be determined according to the surveillance guidelines, including poor bowel preparation, colorectal cancer or suspicious malignance, surgery or colorectal ESD history, those who fail to complete colonoscopy due to unbearable, pathological indications of not polyps, hamartoma or lymphoma polyps, history of ulcerative colitis, and so on. * 4\) Has participated in other clinical trials, signed the informed consent form and is in the surveillance period of other clinical trials. * 5\) Have drug or alcohol abuse or psychological disorder in the past five years. * 6）Pregnancy. * 7）Not suitable for recruitment after investigator evaluation because of other high-risk conditions.

Primary outcome measure(s)

  • surveillance rate — From enrollment to study completion, assessed up to 3 years.
    The numerator is the number of patients with surveillance, and the denominator is the number of all colorectal postpolypectomy patients requiring surveillance.

Trial sites (2)

FacilityCityRegionStatus
Jiangmen Central Hospital Jiangmen Guangdong
Renmin Hospital of Wuhan University Wuhan Hubei

More Renmin Hospital of Wuhan University trials in China

Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer Starting soon
Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions Recruiting
The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy Starting soon
Ivarmacitinib Combined With Camrelizumab and Fruquintinib for Patients With Metastatic Colorectal Cancer After Failure of Second-line or Later Treatment Recruiting
Artificial Intelligence-assisted System in Colonoscopy Recruiting

Other trials for the same condition

Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions Recruiting
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma Recruiting
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography Recruiting
Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology Recruiting
Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05751824 on ClinicalTrials.gov ↗ ← All trials in China